Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The prevalence of EGFR mutations in non-small cell lung cancer in an unselected Caucasian population

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Primary antibiotic resistance of Helicobacter pylori strains among adults and children in a tertiary referral centre in Lithuania

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A short history of microbial biofilms and biofilm infections

    Research output: Contribution to journalReviewResearchpeer-review

  3. Biofilms and host response - helpful or harmful

    Research output: Contribution to journalReviewResearchpeer-review

  4. Diagnosis of biofilm infections in cystic fibrosis patients

    Research output: Contribution to journalReviewResearchpeer-review

  1. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer

    Research output: Contribution to journalReviewResearchpeer-review

  2. Multimodal soft tissue markers for bridging high-resolution diagnostic imaging with therapeutic intervention

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Career Development Training for Interventional Pulmonary Fellows

    Research output: Contribution to journalLetterResearchpeer-review

View graph of relations

EGFR mutation frequencies in unselected Caucasian populations are unknown. This study assesses the prevalence of EGFR mutations in an unselected population-based cohort, and the correlation between mutation and gender, age, ethnicity, smoking habits, and pathological data. NSCLC patients diagnosed in a well-defined Danish population were included. The type of the diagnostic material, and data on smoking were registered. The mutation analyses were investigated by Therascreen EGFR RGQ-PCR Kit or Sanger sequencing. A total of 658 men and 598 women were included. 6.2% were never smokers, 38.9% were ex-smokers, and 54.9% were current smokers. One thousand one hundred and sixty-one (92.4%) patients had sufficient material for mutation analysis. Cytological material was used for 38% of the mutation analyses. 5.4% had mutation in the EGFR gene (4.3% men/6.7% women). 87% were activating mutations. 8.0% of adenocarcinomas, and 1.9% of squamous cell carcinomas were mutated. 29.4%, 4.4% and 2.9% of never, ex- and current smokers were mutated (p < 0.001). No difference in mutation rate was observed between patients with cytology only, histology only or both cytology and histology available. 5.4% of the patients had EGFR mutation. Adenocarcinomas were mutated more often (8.0%) than squamous cell carcinomas (1.9%). Mutations were found in never smokers as well as in former and current smokers. No difference in gender and age regarding mutation status was observed. EGFR mutations analysis was possible in almost all patients with no difference between cytology and histology specimens.

Original languageEnglish
JournalAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Volume123
Issue number2
Pages (from-to)108-15
Number of pages8
ISSN0903-4641
DOIs
Publication statusPublished - Feb 2015

    Research areas

  • Adult, Aged, Aged, 80 and over, Carcinoma, Non-Small-Cell Lung, DNA Mutational Analysis, European Continental Ancestry Group, Female, Humans, Lung Neoplasms, Male, Middle Aged, Mutation, Mutation Rate, Neoplasm Metastasis, Prospective Studies, Receptor, Epidermal Growth Factor, Smoking, Young Adult

ID: 45866088